The Science of Laser Hair Growth

An evidence-based look at how low-level laser therapy (LLLT) has been studied for the scalp and hair — and why the 650nm wavelength is the most clinically validated choice for hair growth stimulation.

What is low-level laser therapy?

Low-level laser therapy (LLLT) — also called photobiomodulation — is the use of specific wavelengths of red laser light to influence cellular activity. In the context of hair, it has been studied for its effects on the hair follicle and the surrounding scalp environment. Unlike heat-based or surgical approaches, LLLT is non-thermal and non-invasive, which is part of why researchers have repeatedly described it as having a favorable safety profile. The 650nm wavelength sits at the heart of this research — it is the most studied wavelength range for scalp applications and the wavelength used in the majority of FDA-cleared laser hair devices.

How it works, in three steps

You don't need a biology degree to follow the basic idea. Here is what happens during a session:

What the clinical evidence shows

1. A 2021 meta-analysis of randomized controlled trials found a significant increase in hair density

Lueangarun and colleagues published a systematic review and meta-analysis in the Journal of Clinical and Aesthetic Dermatology examining home-use low-level light/laser devices for pattern hair loss. Pooling seven double-blind, randomized, sham (placebo)-controlled trials, the analysis found a statistically significant increase in hair density in those treated with LLLT versus sham devices — a standardized mean difference (SMD) of 1.27 (95% CI: 0.99–1.64). Subgroup analysis showed the benefit held across both men and women, and across both comb-type and helmet/cap-type devices. View study →

2. A 2025 meta-analysis of more than 3,000 patients reached the same conclusion

Perez and colleagues, writing in Dermatologic Surgery (2025), conducted a systematic review and meta-analysis of 38 studies covering 3,098 patients across several types of hair loss. For androgenetic alopecia (pattern hair loss) — by far the largest group — the mean change in hair density increased significantly after LLLT compared with placebo, both in shorter courses (SMD 1.14) and longer courses beyond 20 weeks (SMD 1.44). The authors concluded LLLT is "a promising treatment option for patients with androgenetic alopecia." View study →

3. An evidence-based review confirmed safety and efficacy for men and women

Zarei and colleagues at the University of Miami reviewed the available evidence — including randomized controlled trials — in Lasers in Medical Science (2016). They concluded that low-level laser/light therapy is both safe and effective for male and female pattern hair loss, including in patients who had not responded to, or could not tolerate, standard treatments. View study →

4. A review of the literature on safety and efficacy

Afifi and colleagues (2020) reviewed the published literature on LLLT for male and female pattern hair loss, noting reports of increased hair density versus sham treatment and reinforcing the technology's favorable safety record across studies. View study →

Why 650nm?

Not all light is equal. The wavelength determines how light interacts with tissue. 650nm sits in the red light range that has been most extensively studied for scalp applications — it is the wavelength used in the majority of FDA-cleared home laser hair devices and is the primary wavelength studied in the clinical trials referenced above.

Researchers believe 650nm is absorbed by mitochondria inside follicle cells, where it is thought to:

• Support cellular energy production (ATP)
• Support the metabolism of follicular cells
• Help follicles remain in their active growth (anagen) phase
• Help modulate inflammatory signaling around the follicle
• Support microcirculation in the scalp

The Luxuel Laser Cap 128 uses 128 true 650nm laser diodes — the same wavelength at the centre of the peer-reviewed LLLT research.

What actually matters in a device

The research focuses less on any single "magic number" of diodes and more on the fundamentals: wavelength, the dose of energy delivered, session duration, treatment frequency, and how well the device covers the scalp. Luxuel's 128-laser-diode array is designed for broad, even coverage across the crown and scalp, with a built-in timer so each session delivers a consistent, hands-free dose.

Consistency is the key variable

Across the studies above, results came from regular use over a period of weeks to months — not from a single session. Like most parts of a hair-care routine, the evidence supports patience and consistency rather than overnight change.

References

1. Lueangarun S, et al. A Systematic Review and Meta-analysis of Randomized Controlled Trials of FDA-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss. J Clin Aesthet Dermatol. 2021;14(11):E64–E75. PubMed
2. Perez SM, et al. Low-Level Laser and LED Therapy in Alopecia: A Systematic Review and Meta-Analysis. Dermatol Surg. 2025;51(2):179–183. PubMed
3. Zarei M, et al. Low level laser therapy and hair regrowth: an evidence-based review. Lasers Med Sci. 2016;31(2):363–371. PubMed
4. Afifi L, et al. Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair Loss: A Review of the Literature. 2020. PMC

This page is provided for general educational purposes. The studies referenced evaluated low-level laser therapy as a category and do not represent clinical testing of this specific product. The Luxuel Laser Cap 128 is FDA 510(k) cleared under K253231 for hair growth stimulation. It is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary and depend on consistent use over time. Consult a healthcare provider before use if you are pregnant, have a scalp or skin condition, or take photosensitizing medication.